Form 4: Analog Devices CEO Exercises, Sells Shares

Sentiment:

Insider Transaction Report


Analog Devices CEO Vincent Roche exercised stock options and subsequently sold an equal number of shares under a pre-arranged 10b5-1 plan.

Summary

  • Vincent Roche, Chair & CEO of Analog Devices Inc. (ADI), engaged in transactions involving company common stock.
  • On March 2, 2026, Roche exercised 10,000 non-qualified stock options at a price of $94.41 per share.
  • Immediately following the exercise, Roche sold 10,000 shares of common stock at a price of $350 per share.
  • These sales were conducted under a Rule 10b5-1 trading plan adopted on May 23, 2025.
  • Post-transaction, Roche directly holds 155,688.462 shares and indirectly holds 23,515 shares through a grantor retained annuity trust.
  • Roche also retains 34,637 non-qualified stock options.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral event. While a sale by a CEO could be seen negatively, its execution under a pre-arranged 10b5-1 plan makes it a routine personal financial management activity rather than a signal of changing company prospects.

Positives

  • The exercise of options indicates management's prior confidence in the company's long-term value, as the options were granted at a lower price.
  • The sale price of $350 per share is significantly higher than the exercise price of $94.41, indicating a substantial gain for the executive.

Negatives

  • The sale of 10,000 shares by the CEO, even under a 10b5-1 plan, represents a reduction in direct ownership.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider transactions, particularly those executed under Rule 10b5-1 plans, are common for executives managing their personal finances and diversifying their holdings. While a sale might be interpreted negatively, the pre-arranged nature of the plan often mitigates concerns about immediate sentiment regarding the company's prospects. Analog Devices operates in the semiconductor industry, where executive compensation often includes significant equity components.

Related Party Transactions

  • Indirect beneficial ownership of 23,515 shares is held by the Vincent Roche 2024 Grantor Retained Annuity Trust, dated October 3, 2024.

Stakeholder Impact

  • Shareholders: Minimal direct impact as it is a routine insider transaction under a 10b5-1 plan. Could be seen as a slight negative due to reduced insider holding, but offset by the pre-planned nature.
  • Employees, Customers, Suppliers, Creditors: No direct impact.

Key Dates

DateDescription
03/15/2021Date when the non-qualified stock option became fully vested.
10/03/2024Date of the Vincent Roche 2024 Grantor Retained Annuity Trust.
05/23/2025Date the 10b5-1 trading plan was adopted by the reporting person.
03/02/2026Date of the stock option exercise and subsequent sale of common stock.
03/03/2026Signature date of the reporting person's representative.
03/11/2030Expiration date of the non-qualified stock option.

Recommendation

hold

The filing details a routine insider transaction under a pre-established 10b5-1 plan. While the CEO sold shares, the pre-planned nature mitigates concerns about a negative signal regarding the company's future. This event alone does not provide sufficient new information to alter an investment thesis for Analog Devices, thus a 'hold' recommendation is appropriate.

Keywords

Analog Devices, ADI, Vincent Roche, Insider Trading, Form 4, Stock Options, 10b5-1 Plan, CEO Stock Sale, Executive Compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.